Nanocarriers Based on Lipid for Small Interfering RNA Delivery

来源 :International Conference on Nanoscience & Technology,China 2 | 被引量 : 0次 | 上传用户:SuperMMX
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Gene therapy based on small interfering RNA (siRNA) has emerged as a promising therapeutic approach for the treatment of numerous diseases such as cancer, genetic disorders and viral infections.However, insufficient cellular uptake and poor stability have limited its application.Cationic liposome based gene delivery systems have been studied as a potential carrier for delivering genes to target cells for gene therapy.
其他文献
In this presentation, we will be reporting two recent results from our group: Drude soliton dynamics in silicon slow-light photonic crystals [1] and frequency comb dynamics in silicon nitride ring mic
Engineered nanoparticles, even in the absence of toxicity, may interfere with the normal development of the innate/inflammatory response, thereby altering the defensive mechanisms and eventually causi
Tumor metastasis is one of the greatest hurdles for cancer treatment, which accounts for 90% of cancer-associated mortality.Nanodiamond (ND) presents many requisite properties of drug delivery system
Nanoparticle materials with modification are good for serving as shuttles of drug delivery and contrast agents in different biomedical imaging modalities such as magnetic resonance imaging (MRI), comp
Nanodiamonds (NDs), as a new member of the carbon nanoparticles family, have attracted more and more attention in biomedicine recently due to their excellent physical and chemical properties.In this w
The structure and mechanical properties of human tissues may be significantly different under different environment conditions.Although the structure or mechanical property of human cornea has been re
Enzymatic catalysis provides enormous opportunities to use enzymes as catalysts to synthesize molecules with complex structures, particularly fine chemicals and pharmaceutical intermediates.We focus o
Drug delivery development faces numerous challenges, such as improved efficacy and specificity, reduced side effects, sustained release, reduced pain from administration, increased ease of use and saf
Targeted drug delivery vesicles with low immunogenicity and toxicity are urgently needed for clinically used anti-tumor drugs for an enhanced tumor therapy while reduced side effect.We introduced a pr
We report the development of bioconjugated plasmonic vesicles assembled from SERS-encoded amphiphilic gold nanoparticles for cancer-targeted drug delivery.This new type of plasmonic assemblies with a